UiPath (PATH) Beats Q1 Earnings and Revenue Estimates
UiPath (PATH) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of $0.10 per share. This compares to earnings of $0.13 per share a year ago.
Should You Buy, Sell, or Hold UiPath Stock Before Q1 Earnings?
UiPath Inc. PATH is set to report first-quarter fiscal 2026 results on May 29, after the bell.
Insights Into UiPath (PATH) Q1: Wall Street Projections for Key Metrics
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for UiPath (PATH), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended April 2025.
Why UiPath (PATH) Dipped More Than Broader Market Today
UiPath (PATH) closed the most recent trading day at $12.44, moving -1.19% from the previous trading session.
UiPath Shares Down 37% Over a Year: Is a Turnaround in Play?
PATH stock has plunged significantly in a year but has rebounded sharply recently, a recovery or a trap? Here's what investors need to know.
UiPath (PATH) Outperforms Broader Market: What You Need to Know
The latest trading day saw UiPath (PATH) settling at $13.26, representing a +1.3% change from its previous close.
C3.ai vs. UiPath: Which AI Automation Stock Is the Better Buy in 2025?
C3.ai, Inc. AI and UiPath Inc. PATH are both high-profile players in the booming AI automation sector. C3.ai specializes in enterprise AI applications, including predictive maintenance and generative AI tools, while UiPath leads in robotic process automation and is evolving toward “agentic AI” solutions.
UiPath, Inc. (PATH) Is a Trending Stock: Facts to Know Before Betting on It
Recently, Zacks.com users have been paying close attention to UiPath (PATH). This makes it worthwhile to examine what the stock has in store.
Investors Heavily Search UiPath, Inc. (PATH): Here is What You Need to Know
UiPath (PATH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
UiPath Shares Decline 41% in a Year: Is Now the Time to Buy?
With PATH stock recovering after a decline, we assess its current status to decide on the best strategy for the future.
Here is What to Know Beyond Why UiPath, Inc. (PATH) is a Trending Stock
UiPath (PATH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
UiPath's Oversold Status Triggers Cheap Buying Opportunity - Maintain Buy
UiPath's kitchen sink FY2026 guidance has triggered growth concerns after the robust 3Y top/bottom-line performance, with it contributing to the massive selloff thus far. This is worsened by the potentially impacted SaaS demand in both federal and commercial end markets, attributed to the DOGE headwinds and higher recessionary risks. Even so, given the still rich Free Cash Flow generation, robust balance sheet, and the growing ARR, we believe that PATH remains well positioned to outperform from current discounted levels.
